Results 61 to 70 of about 25,891 (205)
A Computational Journey Toward an Optimal Design for Metamaterial Epicardial Passive Sleeves
Passive epicardial sleeves are evaluated in 3D in‐silico heart models to reveal how sleeve geometry, stiffness, anisotropy, and metamaterial architecture influence cardiac mechanics after myocardial infarction. A continuum‐to‐auxetic design exploration shows that region‐specific mechanical engagement can reduce infarct bulging and modulate torsional ...
Vahid Naeini +8 more
wiley +1 more source
ABSTRACT Objective The optimum duration of prophylactic antibiotics after pancreaticoduodenectomy following preoperative biliary drainage to prevent surgical site infections remains controversial. We evaluate whether a prolonged course of prophylactic antibiotics reduces surgical site infection after pancreaticoduodenectomy following biliary drainage ...
Kyohei Matsumoto +9 more
wiley +1 more source
EVALUATION OF THE SPATIAL RESOLUTION IN MONTE CARLO-BASED SPECT/CT RECONSTRUCTION OF 111IN-OCTREOTIDE IMAGES [PDF]
Emma Wikberg +5 more
openalex +1 more source
Background Hyperthyroidism is known to increase the risk of ischemic heart diseases. Octreotide has been reported to attenuate ischemia/reperfusion (I/R) injury.
Randa Salah Gomaa +2 more
doaj +1 more source
Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh +7 more
wiley +1 more source
Burosumab in Unidentifiable Tumor‐Induced Osteomalacia
ABSTRACT Tumor‐induced osteomalacia (TIO) can be challenging due to underlying tumors being either unresectable or unidentifiable. Burosumab, an anti‐FGF23 monoclonal antibody, has been proven to be effective in treating TIO but is currently not subsidized for this indication in Australia.
Yi Shan Der +5 more
wiley +1 more source
Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing’s Syndrome
A 30-year-old Caucasian man presented with severe Cushing’s syndrome (CS) resulting from ectopic adrenocorticotropin syndrome (EAS) from a metastatic pancreatic neuroendocrine tumor.
Andreas G. Moraitis, Richard J. Auchus
doaj +1 more source
Pancreatic Pseudocyst With Thoracic Extension: A Clinicoradiological Case Report
CECT sagittal view shows an enlarged, heterogeneously enhancing pancreas with a peripancreatic collection extending into the posterior mediastinum and compressing the esophagus with massive right pleural fluid noted. ABSTRACT Pancreatic pseudocysts are encapsulated, enzyme‐rich peripancreatic fluid collections that typically develop following acute or ...
Sachchu Thapa +7 more
wiley +1 more source
Treatment of G1 Duodenal Neuroendocrine Tumors With Hepatic Metastasis: A Case Report
ABSTRACT HAIC‐FOLFOX combined with lenvatinib induced complete liver metastasis response and partial primary tumor response in G1 duodenal neuroendocrine tumor, enabling curative resection (13 months recurrence free survival), highlighting a novel conversion strategy for advanced dNETs with liver metastases.
Yuhui Fang +7 more
wiley +1 more source
This Perspective focuses on photocatalyst‐free, photoinduced modifications of biomolecules, emphasizing transformations mediated by electron donor–acceptor complexes. Mechanistic aspects, current limitations, and future opportunities are discussed, providing insight into the field of bioconjugation.
Milene Hornink +3 more
wiley +1 more source

